Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joerg Czech is active.

Publication


Featured researches published by Joerg Czech.


Bioorganic & Medicinal Chemistry Letters | 2003

Design, synthesis, and structure-activity relationship of a new class of amidinophenylurea-based factor VIIa inhibitors.

Otmar Klingler; Hans Matter; Manfred Schudok; S. Paul Bajaj; Joerg Czech; Martin Lorenz; Hans Peter Nestler; Herman Schreuder; Peter Wildgoose

Selective inhibition of coagulation factor VIIa has recently gained attraction as interesting approach towards antithrombotic treatment. Using parallel synthesis supported by structure-based design and X-ray crystallography, we were able to identify a novel series of amidinophenylurea derivatives with remarkable affinity for factor VIIa. The most potent compound displays a K(i) value of 23 nM for factor VIIa.


Cancer Research | 1998

Elucidation of the Mechanism Enabling Tumor Selective Prodrug Monotherapy

Klaus Bosslet; Rainer Straub; Matthias Dr Blumrich; Joerg Czech; Manfred Gerken; Bernhard Sperker; Heyo K. Kroemer; Jean-Pierre Gesson; Michel Koch; Claude Monneret


Journal of Medicinal Chemistry | 1998

Prodrugs of Anthracyclines for Use in Antibody-Directed Enzyme Prodrug Therapy

Jean-Claude Florent; Xia Dong; Sofia Mitaku; Claude Monneret; Jean-Pierre Gesson; Jean-Claude Jacquesy; Martine Mondon; Brigitte Renoux; Solo Andrianomenjanahary; Sylvie Michel; Michel Koch; François Tillequin; Manfred Gerken; Joerg Czech; Rainer Straub; Klaus Bosslet


Archive | 1994

Improved prodrugs for enzyme mediated activation

Klaus Bosslet; Joerg Czech; Dieter Hoffmann; François Tillequin; Jean-Claude Florent; Michel Azoulay; Claude Monneret; Jean-Claude Jacquesy; Jean-Pierre Gesson; Michel Koch; Andrea Vasella; Roland Hoos


Archive | 1993

Fusion proteins for prodrug activation

Mathias Gehrmann; Gerhard Seemann; Klaus Bosslet; Joerg Czech


Archive | 1994

Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy

Klaus Bosslet; Joerg Czech; Dieter Hoffmann


Archive | 1993

Prodrugs, their preparation and use as medicaments

Klaus Bosslet; Joerg Czech; Dieter Hoffmann; Cenek Kolar; Francois Dr Tillequin; Jean-Claude Dr Florent; Michel Dr Azoulay; Claude Prof Monneret; Jean-Claude Prof Jacquesy; Jean-Pierre Prof Gesson; Michel Prof Koch


Archive | 1992

Fusion proteins with monoclonal antibody, Linker and beta Glucuronidase for prodrug activation; preparation and use thereof

Gerhard Seemann; Klaus Bosslet; Joerg Czech; Cenek Kolar; Dieter Hoffmann; Hans-Harald Sedlacek


Archive | 1996

Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coli

Martin Opper; Klaus Bosslet; Joerg Czech


Bioorganic & Medicinal Chemistry Letters | 2004

Structure-based design of amidinophenylurea-derivatives for factor VIIa inhibition

Otmar Klingler; Hans Matter; Manfred Schudok; Monica Donghi; Joerg Czech; Martin Lorenz; Hans Peter Nestler; Hauke Szillat; Herman Schreuder

Collaboration


Dive into the Joerg Czech's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge